Cargando…
Nuclear Receptor Coregulators in Hormone-Dependent Cancers
SIMPLE SUMMARY: Altered nuclear receptor signaling is well-established to contribute to a range of hormone-dependent cancers and therefore they are therapeutic targets, for example in breast and prostate cancer. However, nuclear receptor signaling in the cancer, and in response to therapeutic target...
Autores principales: | Jafari, Hedieh, Hussain, Shahid, Campbell, Moray J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139824/ https://www.ncbi.nlm.nih.gov/pubmed/35626007 http://dx.doi.org/10.3390/cancers14102402 |
Ejemplares similares
-
Expression and role of nuclear receptor coregulators in colorectal cancer
por: Triki, Mouna, et al.
Publicado: (2017) -
The nuclear receptor transcriptional coregulator RIP140
por: Augereau, Patrick, et al.
Publicado: (2006) -
MTA family of coregulators in nuclear receptor biology and pathology
por: Manavathi, Bramanandam, et al.
Publicado: (2007) -
Editorial: Nuclear Receptors and Coregulators in Metabolism and Immunity
por: Fan, Rongrong, et al.
Publicado: (2021) -
Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR
por: Vadlamudi, Ratna K., et al.
Publicado: (2007)